RocketTickers

Cerevel Therapeutics Announces Positive Topline Results for Dari

Long
NASDAQ:CERE   Cerevel Therapeutics Holdings, Inc.
CERE: Cerevel Therapeutics Holdings, Inc.
2022-02-15 06:30:00
Cerevel Therapeutics Announces Positive Topline Results for Darigabat in Phase 1 Clinical Trial in Acute Anxiety
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.